Retatrutide (GLP-3) — Advanced Weight Loss and Metabolic Wellness
$349.00
- Description
Retatrutide
The most advanced weight loss therapy available today
A next generation GLP-3 triple agonist activating GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 trials demonstrated an average body weight reduction of 24.2 percent at 48 weeks, surpassing every approved weight loss medication.
Key Benefits
- Triple receptor activation for maximum metabolic impact
- Average 24.2 percent body weight reduction in Phase 2 trials
- Superior to Semaglutide and Tirzepatide in clinical outcomes
- Reduces appetite, accelerates fat metabolism, and improves blood sugar
Protocol
| Frequency | Dose | Cycle |
|---|---|---|
| Once / week | 12mg | Ongoing |
Pricing
|
Starter Vial 12mg $349 No auto-renewal |
Monthly Vial 48mg $949 Flexible supply |
12 Week $3,199 No auto-renewal |
Administration Instructions:
